Insulin Delivery Devices Market
                     Insulin Delivery Devices Market  2021 to Biggest Trials 
and Prospect in Healthcare Sector 
Insulin Delivery Devices Market to 2025 - 
Global Analysis and Forecasts By Product 
(Insulin Pens, Insulin Pumps, Insulin 
Syringes, Pen Needles, and Others), End 
User (Patients/Homecare and Hospitals & 
Clinics), and Geography
Insulin Delivery Devices  Market 
Current and future Market Scenario
 The insulin delivery devices market accounted to US$ 11,869.0 Mn in 2017 and is expected to grow at a CAGR of 8.7% 
during the forecast period 2018 – 2025, to account to US$ 22,830.0 Mn by 2025.
 North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast 
period. North American market is driven by the factors such as, rising geriatric population and increasing prevalence of 
diabetes in the region.
 The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller 
required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices.
Key Findings
Market Insights
Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and 
mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised 
to become one of the most significant transformation with a heavy impact on the social and economic level across the 
globe. These population is growing exponentially worldwide. According to a report of United Nation (2017), there were 
approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 
2050.
 The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller 
required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices
Insulin Delivery Devices  Market 
 
Market Segments
 
End User (Patients/Homecare Geography (North America, 
By Product (Insulin Pens, Insulin 
and Hospitals & Clinics) Europe, Asia Pacific (APAC), Middle 
Pumps, Insulin Syringes, Pen East & Africa (MEA), South America 
Needles, and Others) and Central America (SCAM))
Dominating Segments
Product Insights
 For instance, in September 2016, the FDA announced their first automatically automatic glucose monitoring 
device, Medtronic’s MiniMed 670G which is a hybrid closed looped system that provide appropriate basal insulin 
doses in people 14 years of age and older with type 1 diabetes. In addition, in July 2018, Abbott announced to 
have a FDA approval for the FreeStyle Libre 14 day Flash Glucose Monitoring system that allows people with 
diabetes to wear the sensor up to 14 days with high accuracy. These advancements are expected to offer 
increasing demand for the products, hence providing better share to the market players.
 Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPHE100000819/
Dominating Segments
The report segments the global Insulin Delivery Devices market as follows:
 
By Product
Insulin Pens
Reusable Insulin Pens
Disposable Insulin Pens
Insulin Pumps
Tube Pumps
Patch Pumps
Insulin Syringes
Pen Needles
Standard Pen Needles
Safety Pen Needles
Others
Dominating Segments
By End User
Patients/Homecare
Hospitals & Clinics
By Geography
North America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)
South America (SAM)
Insulin Delivery Devices  Market  
Leading Players
Company Profiles in Insulin Delivery Devices  Market are:
BD
Novo Nordisk A/S
B. Braun Melsungen AG
Insulet Corporation
Medtronic
Tandem Diabetes Care, Inc.
Eli Lilly and Company
Biocon
Owen Mumford, Ltd.
Sanofi
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
 
 Insulin Delivery Devices  Market 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/insulin-delivery-devices-market
 
Thank You! 
Thank You!